IRIS
DEIANA, Giovanni Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.349
AS - Asia 2.397
EU - Europa 1.886
SA - Sud America 1.565
AF - Africa 75
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 10.288
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.268
BR - Brasile 1.406
SG - Singapore 988
CN - Cina 830
UA - Ucraina 597
SE - Svezia 299
FR - Francia 283
DE - Germania 254
HK - Hong Kong 226
IT - Italia 122
FI - Finlandia 103
VN - Vietnam 77
GB - Regno Unito 73
AR - Argentina 57
TR - Turchia 48
IN - India 33
MX - Messico 32
ZA - Sudafrica 30
RU - Federazione Russa 29
VE - Venezuela 24
BD - Bangladesh 23
EC - Ecuador 23
IQ - Iraq 23
BE - Belgio 22
CA - Canada 21
UZ - Uzbekistan 20
PL - Polonia 19
CO - Colombia 16
ES - Italia 16
KR - Corea 16
MA - Marocco 14
ID - Indonesia 13
JP - Giappone 13
AE - Emirati Arabi Uniti 11
CL - Cile 11
NL - Olanda 11
PK - Pakistan 11
AT - Austria 10
LT - Lituania 10
NP - Nepal 10
PY - Paraguay 10
CZ - Repubblica Ceca 9
DO - Repubblica Dominicana 9
JO - Giordania 8
PE - Perù 8
AU - Australia 7
UY - Uruguay 7
AZ - Azerbaigian 6
HN - Honduras 6
IR - Iran 6
DZ - Algeria 5
IL - Israele 5
KE - Kenya 5
KZ - Kazakistan 5
NI - Nicaragua 5
RO - Romania 5
EG - Egitto 4
EU - Europa 4
GR - Grecia 4
OM - Oman 4
TN - Tunisia 4
BO - Bolivia 3
BW - Botswana 3
CI - Costa d'Avorio 3
GA - Gabon 3
HR - Croazia 3
LB - Libano 3
NZ - Nuova Zelanda 3
RS - Serbia 3
AM - Armenia 2
BH - Bahrain 2
CH - Svizzera 2
CR - Costa Rica 2
IE - Irlanda 2
ME - Montenegro 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
QA - Qatar 2
SA - Arabia Saudita 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
MD - Moldavia 1
MN - Mongolia 1
PT - Portogallo 1
SN - Senegal 1
SV - El Salvador 1
Totale 10.285
Salva come PNG Salva come JPEG
Città #
Dallas 1.627
Chandler 537
Singapore 495
Jacksonville 372
Hong Kong 225
Beijing 186
Princeton 185
Dearborn 162
Nanjing 152
São Paulo 115
Ashburn 109
Wilmington 93
New York 76
Nanchang 69
Shanghai 62
Ann Arbor 60
Boardman 60
Los Angeles 47
Tianjin 41
Hebei 40
Shenyang 38
Woodbridge 36
Changsha 33
Rio de Janeiro 33
Belo Horizonte 32
Ho Chi Minh City 32
Jiaxing 26
Porto Alegre 25
Rome 25
Sassari 24
Brasília 22
Brussels 22
Buffalo 21
Campinas 21
Curitiba 20
Johannesburg 20
Denver 19
Munich 19
Santa Clara 19
Jinan 18
Tashkent 18
Warsaw 17
Seoul 16
Bochum 15
Hanoi 15
Andover 14
Hangzhou 14
Baghdad 13
Ribeirão Preto 13
Salvador 13
Goiânia 12
Mexico City 12
San Francisco 12
Tokyo 12
Helsinki 11
Izmir 11
Kunming 11
Zhengzhou 11
Brooklyn 10
Caxias do Sul 10
Dhaka 10
Guangzhou 10
Guarulhos 10
Istanbul 10
London 10
Duque de Caxias 9
Ipatinga 9
Norwalk 9
Sorocaba 9
Toronto 9
Volta Redonda 9
Amman 8
Campo Grande 8
Canoas 8
Carapicuíba 8
Dubai 8
Florianópolis 8
Fortaleza 8
Guayaquil 8
Itajaí 8
Mauá 8
Medellín 8
Montreal 8
Ningbo 8
São José dos Campos 8
Amsterdam 7
Bauru 7
Brno 7
Montevideo 7
Poplar 7
São Bernardo do Campo 7
São José do Rio Preto 7
Valencia 7
Vienna 7
Baku 6
Bragança Paulista 6
Caracas 6
Casablanca 6
Franca 6
Houston 6
Totale 5.793
Salva come PNG Salva come JPEG
Nome #
A liquid chromatography-mass spectrometry study on the spirocyclization of ninhydrin with the aminothiols 260
"Erratic" complex partial status epilepticus as a presenting feature of MELAS 189
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 181
Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice 178
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 173
Beneficial effect of risperidone on behavioral disturbances associated with hyperostosis frontalis interna 164
Acute hyponatremia and neuroleptic malignant syndrome 164
Acute hyponatremia and neuroleptic malignant syndrome in Parkinson's disease 157
Herv-k modulates the immune response in als patients 155
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 150
Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls 148
A simple capillary electrophoresis method for the analysis of lamotrigine in serum 147
Carbamazepine in delayed-onset cerebellar tremor 145
Carbamazepine therapy for steroid psychosis 144
Brain intgerstitial fluid amino acids in pentylene-tetrazol-induced status eplilepticus 138
Focal and secondarily generalised convulsive status epilepticus induced by thiocolchicoside in the rat 137
Asterixis and mild encephalopathy induced by gabapentin 133
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 130
Brain interstitial fluid amino acids in pentylene-tetrazol-induced status eplilepticus 130
Hyperthermia, choreic dyskinesias and increased motor tone in Wernicke's encephalopathy 127
Brain interstitial fluid collected trhough implanted tissue cages 126
Beneficial effect of fluoxetine in hyperekplexia 125
Reduced intravenous glutathione in the treatment of early Parkinson's disease 123
Delayedonset cerebellar tremors (DOCT): natural history and treatment 119
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 119
Acute hyponatremia and neuroleptic malignant syndrome in Parkinson’s Disease 118
Determination of L-alpha aminoadipic acid levels in human and experimental epilepsy 117
Epilepsy in definite multiple sclerosis (MS): comparison of two hospitalisation-based series in Sardinia 117
Carbamazepine in delayed-onset cerebellar tremor 115
Epilepsy in definite multiple sclerosis (MS): comparison of two hospitalisation-based series in Sardinia 114
Expressive aphasia exacerbated by lamotrigine and gabapentin 113
Attività epilettogena del tiocolchicoside nell'uomo e nel ratto wistar 113
Brain interstitial fluid collected through implanted tissue cages 111
Neuroleptic maglignant syndrome and related syndromes in a neurological popupation 110
Detection of Chlamydia Pneumoniae in the CSF of Sardinian patients with multiple sclerosis in the presence or absence of oligoclonal bands 109
Exploratory screening for Fabry's disease in young adults with cerebrovascular disorders in northern Sardinia 108
Carbamazepine, clonazepam and focal reflex proprioceptive seizures 107
Tache Noire in a Patient with Acute Q Fever 107
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 107
Excitatory amino acids in brain interstitial fluid during sustained pentylenetetrazole-induced seizures 105
Complex partial status epilepticus as presenting features of MELAS: Case report and review of literature 104
Detection of Chlamydia Pneumoniae In the CSF of Sardinian Patients With Multiple Sclerosis In The Presence Or Absence Of Oligoclonal Bands 102
Epilepsy in multiple sclerosis: Does AED resistances predict a worse outcome of disability? 101
Focal e secondarily generalized convulsive status epilepticus induced by thiocolchicoside in the rat 101
Reduced intravenous glutathione in Parkinson's disease 100
Ceftriaxone for Alexander's Disease: A Four-Year Follow-Up 99
Intravenous glutathione in patients with Parkinson's disease 96
Increase of alpha-aminoadipate in brain IF during PTZ-induced status epilepticus 96
Cerebral and cerebellar diaschisis following carbamazepine therapy 96
Diagnostics of myasthenic syndromes: detection of anti-AChR and anti-MuSK antibodies 95
Epileptogenic activity of thiocolchicoside 94
Urine bikunin as a marker of renal impairment in Fabry's disease 92
Intrathecal overproduction of ceruloplasmin in patients with multiple sclerosis 91
MuSK antibody-positive, seronegative myasthenia gravis in two sisters 91
Co-variation of free amino acids in brain interstitial fluid during pentylenetetrazole-induced convulsive status epilepticus 91
Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies 91
Ceruloplasmin and oxidative stress in multiple sclerosis 90
Carbamazepine, clonazepam and focal reflex proprioceptives seizures 89
Detection of Chlamydia Pneumoniae in the CSF of Sardinian patients with multiple sclerosis in the presence or absence of oligoclonal bands 89
Siti di tremore "rubrale" 89
Ictus giovanile e Malattia di Fabry: lo stato dell’arte in Sardegna 89
Post-ischemic cerebellar tremors and axonal sprouting in humans 88
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 88
Risperidone, neuroleptic malignant sindrome and probable dementia with Lewy bodies 87
Levetiracetam in stiff-person syndrome 87
Complex partial status epilepticus as presenting feature of MELAS: case report and rewiew of literature 87
Cytokines and multiple sclerosis severity: no correlation among Sardinians 87
Non-fluent speech in patients with partial epilepsy: Beneficial effect of levetiracetam 86
Open study of the activity and tolerability of reduced intravenous glutathione in Parkinson's disease 86
Reduced intravenous glutathione in the treatment of early Parkinson’s Disease 82
Successful screening for Fabry disease in patients with juvenile stroke in North Sardinia 82
Diaschisis, "Rossi -Effect", and antiepileptic action of carbamazepine 82
In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulation 81
Preliminary experience with fluoxetine in primary focal dystonias 81
Encephalopathies related to antiepileptic drugs 81
Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies 81
Co-variation of free amino acids in brain interstitial fluid during pentylenetetrazol-induced convulsive status epilepticus 81
Status epileptics induced by administration of thiocolchicoside to lithium-pretreated rats 80
Neuroleptic malignant syndrome and sudden death after combined zuclopenthixol/trihexiphenidyl withdrawal 79
Pharmacology of delayed-onset cerebellar tremors 78
Epilepsy in multiple sclerosis: does predict a worse outcome of disability? 78
Epidemiology of seropositive myasthenia gravis in Sardinia: A population-based study in the district of Sassari 75
Neurological disorders associated with Mycoplasma pneumoniae infection 75
Chronic parkinsonism after use of diquat: clinical and MRI studies 75
Cerebrospinal fluid gamma-glutamyl transpeptidase in multiple sclerosis 74
Neuroleptic maglignant syndrome and related syndromes in a neurological population 73
Delayed-onset cerebellar tremor after stroke 72
Non – fluent spech in patients with partial epilepsy: beneficial effect of levetiracetam 72
Pharmacology of delayed-onset cerebellar tremors 71
Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges 70
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 69
Glycosaminoglycans and fabry’s disease 68
Discinesie bucco-linguali indotte dal fenobarbitale 65
Familial autoimmune MuSK positive myasthenia gravis 64
Multiple sclerosis: correlation between cytokine production and disease progression in Sardinians 61
Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus 60
Ceftriaxone has a therapeutic role in Alexander disease 58
Effetti avversi psichiatrici da steroidi e carbamazepina 57
Topiramate in patients with cerebellar tremor: a controlled trial 47
Neuroimaging leads to recognition of previously undiagnosed Fabry 43
Totale 10.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.665
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021559 0 0 0 0 0 66 98 3 150 146 54 42
2021/2022455 95 12 2 19 3 0 21 31 43 17 52 160
2022/20231.070 99 58 9 176 128 196 0 115 194 12 51 32
2023/2024320 54 41 10 8 80 21 2 20 9 7 26 42
2024/20252.834 71 13 177 55 145 68 210 531 1.020 355 104 85
2025/20262.999 175 1.071 772 593 335 53 0 0 0 0 0 0
Totale 10.358